Top ▲
Target id: 1539
Nomenclature: serine/threonine kinase 32C
Abbreviated Name: YANK3
Family: YANK family
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 486 | 10q26.3 | STK32C | serine/threonine kinase 32C | |
Mouse | - | 488 | 7 F4 | Stk32c | serine/threonine kinase 32C | |
Rat | - | 488 | 1q41 | Stk32c | serine/threonine kinase 32C |
Previous and Unofficial Names ![]() |
PKE | Pkek |
Database Links ![]() |
|
Alphafold | Q86UX6 (Hs), Q8QZV4 (Mm) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL5405 (Hs) |
Ensembl Gene | ENSG00000165752 (Hs), ENSMUSG00000015981 (Mm), ENSRNOG00000006962 (Rn) |
Entrez Gene | 282974 (Hs), 57740 (Mm), 365381 (Rn) |
Human Protein Atlas | ENSG00000165752 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:282974 (Hs), mmu:57740 (Mm), rno:365381 (Rn) |
Pharos | Q86UX6 (Hs) |
RefSeq Nucleotide | NM_173575 (Hs), NM_021302 (Mm), NM_001108922 (Rn) |
RefSeq Protein | NP_775846 (Hs), NP_001156012 (Mm), NP_067277 (Mm), NP_001102392 (Rn) |
UniProtKB | Q86UX6 (Hs), Q8QZV4 (Mm) |
Wikipedia | STK32C (Hs) |
Enzyme Reaction ![]() |
||||
|
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: YANK3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
YANK family: serine/threonine kinase 32C. Last modified on 18/08/2014. Accessed on 25/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1539.